Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Zifu Pharmaceutical is a leading Chinese medical technology company specializing in non-invasive gastrointestinal diagnostic solutions. The company's flagship technology is the Magnetic Controlled Capsule Endoscope (MCE), which allows for a comprehensive and painless examination of the stomach and small intestine without the need for anesthesia. By integrating advanced robotics, high-definition imaging, and artificial intelligence, Zifu provides a patient-friendly alternative to traditional invasive gastroscopy. The company maintains a strong focus on the early screening and diagnosis of digestive tract cancers and other chronic gastrointestinal conditions. Headquartered in Shenzhen, Zifu operates large-scale manufacturing facilities and collaborates with top-tier medical institutions to advance endoscopic technology. Their products are widely deployed across hospitals and health check-up centers throughout China and are expanding into international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 深圳市资福药业.